Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding grant of 37,500 ESOP Options.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has informed the stock exchanges that its Nomination and Remuneration Committee approved the grant of 37,500 Employee Stock Options (ESOPs) on May 6, 2025. These options are issued under the company's existing ESOP Plan, 2022, at an exercise price of Rs. 199.95 per option. Each option is convertible into one equity share of Rs. 2.00 face value. The options will vest in four equal annual tranches starting from the first anniversary of the grant date.
This is a routine ESOP grant and represents a small dilution (~37,500 shares). It is unlikely to materially affect the share price but signals that the company is using stock-based incentives to retain or reward employees.